Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00496171
Status:
TERMINATED
Last Update Posted:
2009-01-16
First Post:
2007-07-03
Brief Title:
Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers
Sponsor:
Photocure
Organization:
Photocure
Study Overview
Official Title:
A Phase I Hexaminolevulinate HAL Dose-Finding Study Applying Different Formulations to the Cervix in Healthy Volunteers
Status:
TERMINATED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine the most effective formulation of HAL for release of hexaminolevulinate to the cervical epithelium at different doses
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None